Randomized controlled trial of inhaled nitric oxide for the treatment of microcirculatory dysfunction in patients with sepsis

Critical Care Medicine

Volumn 42, Issue 12, 2014, Pages 2482-2492

  Trzeciak, Stephen ^a   Glaspey, Lindsey J ^a   Dellinger, R Phillip ^a   Durflinger, Paige ^a   Anderson, Keith ^a   Dezfulian, Cameron ^b   Roberts, Brian W ^a   Chansky, Michael E ^a   Parrillo, Joseph E ^a   Hollenberg, Steven M ^a  

^a Division of Female Pelvic Medicine and Reconstructive Surgery   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Clinical trial; Inhaled nitric oxide; Microcirculation; Nitric oxide; Resuscitation; Sepsis; Septic shock; Severe sepsis

Indexed keywords

DRUG METABOLITE; HYPERTENSIVE AGENT; LACTIC ACID; NITRIC OXIDE; NITRITE; VASOCONSTRICTOR AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LACTATE BLOOD LEVEL; MALE; MICROANGIOPATHY; MICROCIRCULATION; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SIDE EFFECT; SIDESTREAM DARKFIELD VIDEO MICROSCOPY; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; VIDEO MICROSCOPY; AGED; ARTIFICIAL VENTILATION; BLOOD; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; INHALATIONAL DRUG ADMINISTRATION; INTENSIVE CARE UNIT; LENGTH OF STAY; MIDDLE AGED; MORTALITY; MOUTH; PATHOPHYSIOLOGY; RESUSCITATION; UNIVERSITY HOSPITAL; VASCULARIZATION;

ACADEMIC MEDICAL CENTERS; ADMINISTRATION, INHALATION; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LACTIC ACID; LENGTH OF STAY; MALE; MICROCIRCULATION; MIDDLE AGED; MOUTH FLOOR; MULTIPLE ORGAN FAILURE; NITRIC OXIDE; RESPIRATION, ARTIFICIAL; RESUSCITATION; SEPSIS; VASOCONSTRICTOR AGENTS;

EID: 84924839780     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000000549     Document Type: Article

References (78)

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001;29:1303-1310
2. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003;348:138-150
3. Spronk PE, Zandstra DF, Ince C: Bench-to-bedside review: Sepsis is a disease of the microcirculation. Crit Care 2004;8:462-468
4. De Backer D, Creteur J, Preiser JC, et al: Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med 2002;166:98-104
5. Edul VS, Enrico C, Laviolle B, et al: Quantitative assessment of the microcirculation in healthy volunteers and in patients with septic shock. Crit Care Med 2012;40:1443-1448
6. Trzeciak S, Dellinger RP, Parrillo JE, et al; Microcirculatory Alterations in Resuscitation and Shock Investigators: Early microcirculatory perfusion derangements in patients with severe sepsis and septic shock: Relationship to hemodynamics, oxygen transport, and survival. Ann Emerg Med 2007;49:88-98, 98.e1-98.e2
7. Hernandez G, Boerma EC, Dubin A, et al: Severe abnormalities in microvascular perfused vessel density are associated to organ dysfunctions and mortality and can be predicted by hyperlactatemia and norepinephrine requirements in septic shock patients. J Crit Care 2013;28:538.e9-538.e14
8. Trzeciak S, McCoy JV, Phillip Dellinger R, et al; Microcirculatory Alterations in Resuscitation and Shock (MARS) investigators: Early increases in microcirculatory perfusion during protocol-directed resuscitation are associated with reduced multi-organ failure at 24 h in patients with sepsis. Intensive Care Med 2008;34:2210-2217
9. Trzeciak S, Cinel I, Dellinger RP, et al; Microcirculatory Alterations in Resuscitation and Shock (MARS) Investigators: Resuscitating the microcirculation in sepsis: The central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med 2008;15:399-413
10. Spronk PE, Ince C, Gardien MJ, et al: Nitroglycerin in septic shock after intravascular volume resuscitation. Lancet 2002;360:1395-1396
11. Lamontagne F, Meade M, Ondiveeran HK, et al: Nitric oxide donors in sepsis: A systematic review of clinical and in vivo preclinical data. Shock 2008;30:653-659
12. Cannon RO III, Schechter AN, Panza JA, et al: Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest 2001;108:279-287
13. Fox-Robichaud A, Payne D, Hasan SU, et al: Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J Clin Invest 1998;101:2497-2505
14. Gianetti J, Del Sarto P, Bevilacqua S, et al: Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg 2004;127:44-50
15. Lang JD Jr, Teng X, Chumley P, et al: Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J Clin Invest 2007;117:2583-2591
16. Mathru M, Huda R, Solanki DR, et al: Inhaled nitric oxide attenuates reperfusion inflammatory responses in humans. Anesthesiology 2007;106:275-282
17. Ng ES, Jourd'heuil D, McCord JM, et al: Enhanced S-nitroso-albumin formation from inhaled NO during ischemia/reperfusion. Circ Res 2004;94:559-565
18. Gladwin MT, Shelhamer JH, Schechter AN, et al: Role of circulating nitrite and S-nitrosohemoglobin in the regulation of regional blood flow in humans. Proc Natl Acad Sci U S A 2000;97:11482-11487
19. Jones AE, Shapiro NI, Trzeciak S, et al; Emergency Medicine Shock Research Network (EMShockNet) Investigators: Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: A randomized clinical trial. JAMA 2010;303:739-746
20. Rivers E, Nguyen B, Havstad S, et al; Early Goal-Directed Therapy Collaborative Group: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-1377
21. Neonatal Inhaled Nitric Oxide Study Group: Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure. N Engl J Med 1997;336:597-604
22. Ballard RA, Truog WE, Cnaan A, et al; NO CLD Study Group: Inhaled nitric oxide in preterm infants undergoing mechanical ventilation. N Engl J Med 2006;355:343-353
23. Clark RH, Kueser TJ, Walker MW, et al: Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical Inhaled Nitric Oxide Research Group. N Engl J Med 2000;342:469-474
24. Dellinger RP, Levy MM, Rhodes A, et al; Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving sepsis campaign: International guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013;41:580-637
25. Trzeciak S, Dellinger RP, Abate NL, et al: Translating research to clinical practice: A 1-year experience with implementing early goaldirected therapy for septic shock in the emergency department. Chest 2006;129:225-232
26. Ashutosh K, Phadke K, Jackson JF, et al: Use of nitric oxide inhalation in chronic obstructive pulmonary disease. Thorax 2000;55:109-113
27. Capellier G, Jacques T, Balvay P, et al: Inhaled nitric oxide in patients with pulmonary embolism. Intensive Care Med 1997;23:1089-1092
28. Newhart J: Delivery of nitric oxide via vapotherm. In: American Association of Respiratory Care Congress. San Diego, CA, 2004 (abstract)
29. Goedhart PT, Khalilzada M, Bezemer R, et al: Sidestream Dark Field (SDF) imaging: A novel stroboscopic LED ring-based imaging modality for clinical assessment of the microcirculation. Opt Express 2007;15:15101-15114
30. Groner W, Winkelman JW, Harris AG, et al: Orthogonal polarization spectral imaging: A new method for study of the microcirculation. Nat Med 1999;5:1209-1212
31. Mathura KR, Vollebregt KC, Boer K, et al: Comparison of OPS imaging and conventional capillary microscopy to study the human microcirculation. J Appl Physiol (1985) 2001;91:74-78
32. Harris AG, Sinitsina I, Messmer K: The Cytoscan Model E-II, a new reflectance microscope for intravital microscopy: Comparison with the standard fluorescence method. J Vasc Res 2000;37:469-476
33. Sakr Y, Dubois MJ, De Backer D, et al: Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004;32:1825-1831
34. Weil MH, Nakagawa Y, Tang W, et al: Sublingual capnometry: A new noninvasive measurement for diagnosis and quantitation of severity of circulatory shock. Crit Care Med 1999;27:1225-1229
35. De Backer D, Donadello K, Sakr Y, et al: Microcirculatory alterations in patients with severe sepsis: Impact of time of assessment and relationship with outcome. Crit Care Med 2013;41:791-799
36. Pelletier MM, Kleinbongard P, Ringwood L, et al: The measurement of blood and plasma nitrite by chemiluminescence: Pitfalls and solutions. Free Radic Biol Med 2006;41:541-548
37. Jones AE, Trzeciak S, Kline JA: The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 2009;37:1649-1654
38. Levy MM, Macias WL, Vincent JL, et al: Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med 2005;33:2194-2201
39. Lewis RJ, Viele K, Broglio K, et al: An adaptive, phase II, dose-finding clinical trial design to evaluate L-carnitine in the treatment of septic shock based on efficacy and predictive probability of subsequent phase III success. Crit Care Med 2013;41:1674-1678
40. Shapiro N, Howell MD, Bates DW, et al: The association of sepsis syndrome and organ dysfunction with mortality in emergency department patients with suspected infection. Ann Emerg Med 2006;48:583-590, 590.e1
41. Ferreira FL, Bota DP, Bross A, et al: Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA 2001;286:1754-1758
42. Ellis CG, Bateman RM, Sharpe MD, et al: Effect of a maldistribution of microvascular blood flow on capillary O (2) extraction in sepsis. Am J Physiol Heart Circ Physiol 2002;282:H156-H164
43. Farquhar I, Martin CM, Lam C, et al: Decreased capillary density in vivo in bowel mucosa of rats with normotensive sepsis. J Surg Res 1996;61:190-196
44. Lam C, Tyml K, Martin C, et al: Microvascular perfusion is impaired in a rat model of normotensive sepsis. J Clin Invest 1994;94:2077-2083
45. Lundin S, Mang H, Smithies M, et al: Inhalation of nitric oxide in acute lung injury: Results of a European multicentre study. The European Study Group of Inhaled Nitric Oxide. Intensive Care Med 1999;25:911-919
46. Ince C: The microcirculation is the motor of sepsis. Crit Care 2005;9(Suppl 4):S13-S19
47. Hollenberg SM, Cunnion RE, Zimmerberg J: Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to catecholamines in septic rats. Am J Physiol 1993;264:H660-H663
48. Hollenberg SM, Easington CR, Osman J, et al: Effects of nitric oxide synthase inhibition on microvascular reactivity in septic mice. Shock 1999;12:262-267
49. Hollenberg SM, Piotrowski MJ, Parrillo JE: Nitric oxide synthase inhibition reverses arteriolar hyporesponsiveness to endothelin-1 in septic rats. Am J Physiol 1997;272:R969-R974
50. Avontuur JA, Bruining HA, Ince C: Inhibition of nitric oxide synthesis causes myocardial ischemia in endotoxemic rats. Circ Res 1995;76:418-425
51. Kubes P, Granger DN: Nitric oxide modulates microvascular permeability. Am J Physiol 1992;262:H611-H615
52. Nishida J, McCuskey RS, McDonnell D, et al: Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol 1994;267:G1135-G1141
53. Spain DA, Wilson MA, Bar-Natan MF, et al: Nitric oxide synthase inhibition aggravates intestinal microvascular vasoconstriction and hypoperfusion of bacteremia. J Trauma 1994;36:720-725
54. Spain DA, Wilson MA, Garrison RN: Nitric oxide synthase inhibition exacerbates sepsis-induced renal hypoperfusion. Surgery 1994;116:322-330; discussion 330-331
55. Tribl B, Bateman RM, Milkovich S, et al: Effect of nitric oxide on capillary hemodynamics and cell injury in the pancreas during Pseudomonas pneumonia-induced sepsis. Am J Physiol Heart Circ Physiol 2004;286:H340-H345
56. López A, Lorente JA, Steingrub J, et al: Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock. Crit Care Med 2004;32:21-30
57. Cunha FQ, Assreuy J, Moss DW, et al: Differential induction of nitric oxide synthase in various organs of the mouse during endotoxaemia: Role of TNF-alpha and IL-1-beta. Immunology 1994;81:211-215
58. Morin MJ, Unno N, Hodin RA, et al: Differential expression of inducible nitric oxide synthase messenger RNA along the longitudinal and crypt-villus axes of the intestine in endotoxemic rats. Crit Care Med 1998;26:1258-1264
59. Ince C, Sinaasappel M: Microcirculatory oxygenation and shunting in sepsis and shock. Crit Care Med 1999;27:1369-1377
60. Dellinger RP, Zimmerman JL, Taylor RW, et al: Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase II trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 1998;26:15-23
61. Taylor RW, Zimmerman JL, Dellinger RP, et al; Inhaled Nitric Oxide in ARDS Study Group: Low-dose inhaled nitric oxide in patients with acute lung injury: A randomized controlled trial. JAMA 2004;291:1603-1609
62. Hataishi R, Rodrigues AC, Neilan TG, et al: Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 2006;291:H379-H384
63. Liu X, Huang Y, Pokreisz P, et al: Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion. J Am Coll Cardiol 2007;50:808-817
64. Troncy E, Francoeur M, Salazkin I, et al: Extra-pulmonary effects of inhaled nitric oxide in swine with and without phenylephrine. Br J Anaesth 1997;79:631-640
65. Bloomfield GL, Sweeney LB, Fisher BJ, et al: Delayed administration of inhaled nitric oxide preserves alveolar-capillary membrane integrity in porcine gram-negative sepsis. Arch Surg 1997;132:65-75
66. Nevière R, Guery B, Mordon S, et al: Inhaled NO reduces leukocyteendothelial cell interactions and myocardial dysfunction in endotoxemic rats. Am J Physiol Heart Circ Physiol 2000;278:H1783-H1790
67. Fox-Robichaud A, Payne D, Kubes P: Inhaled NO reaches distal vasculatures to inhibit endothelium-but not leukocyte-dependent cell adhesion. Am J Physiol 1999;277:L1224-L1231
68. Kubes P, Payne D, Grisham MB, et al: Inhaled NO impacts vascular but not extravascular compartments in postischemic peripheral organs. Am J Physiol 1999;277:H676-H682
69. Kubes P, Kurose I, Granger DN: NO donors prevent integrin-induced leukocyte adhesion but not P-selectin-dependent rolling in postischemic venules. Am J Physiol 1994;267:H931-H937
70. Sato Y, Walley KR, Klut ME, et al: Nitric oxide reduces the sequestration of polymorphonuclear leukocytes in lung by changing deformability and CD18 expression. Am J Respir Crit Care Med 1999;159:1469-1476
71. Walley KR, McDonald TE, Higashimoto Y, et al: Modulation of proinflammatory cytokines by nitric oxide in murine acute lung injury. Am J Respir Crit Care Med 1999;160:698-704
72. De Backer D, Creteur J, Dubois MJ, et al: The effects of dobutamine on microcirculatory alterations in patients with septic shock are independent of its systemic effects. Crit Care Med 2006;34:403-408
73. Enrico C, Kanoore Edul VS, Vazquez AR, et al: Systemic and microcirculatory effects of dobutamine in patients with septic shock. J Crit Care 2012;27:630-638
74. Morelli A, Donati A, Ertmer C, et al: Levosimendan for resuscitating the microcirculation in patients with septic shock: A randomized controlled study. Crit Care 2010;14:R232
75. De Backer D, Verdant C, Chierego M, et al: Effects of drotrecogin alfa activated on microcirculatory alterations in patients with severe sepsis. Crit Care Med 2006;34:1918-1924
76. Boerma EC, Koopmans M, Konijn A, et al: Effects of nitroglycerin on sublingual microcirculatory blood flow in patients with severe sepsis/septic shock after a strict resuscitation protocol: A double-blind randomized placebo controlled trial. Crit Care Med 2010;38:93-100
77. He X, Su F, Velissaris D, et al: Administration of tetrahydrobiopterin improves the microcirculation and outcome in an ovine model of septic shock. Crit Care Med 2012;40:2833-2840
78. Singer M, De Santis V, Vitale D, et al: Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet 2004;364:545-548